{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:23:25Z","timestamp":1791487405400,"version":"4.3.4"},"reference-count":44,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Long\u2010acting cabotegravir (CAB LA) is the first LA agent approved for HIV pre\u2010exposure prophylaxis. EBONI (NCT05514509) is a Phase 4 implementation study evaluating the implementation of CAB LA delivery to Black cis\u2010 and transgender (cis\u2010and\u2010trans) women in clinics located in the United States, including infectious disease (ID), primary care (PC) and women's health (WH) clinics. We present interim perspectives, considerations and strategies from healthcare professionals\u2019 (HCPs\u2019) experiences during the initial implementation stages of administering CAB LA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From August 2022 to June 2024, through quantitative surveys (prior to implementation [baseline] and Month 4 [M4]) and\/or structured qualitative interviews (M4), HCPs provided their perceptions and experiences of integrating CAB LA in their clinical settings that served Black cis\u2010and\u2010trans women. Monthly implementation monitoring (IM) calls were also conducted. Survey data were analysed using descriptive statistics. Qualitative and IM data were coded and analysed using a Framework Analysis approach grounded in the Consolidated Framework for Implementation Research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety\u2010two HCPs across 20 sites completed baseline and M4 surveys; 57% were cisgender female and 43% were Black. HCPs across clinic types developed innovative approaches to support CAB LA implementation, with few HCPs (&lt;\u00a010%) reporting concerns about practice preparation. Initial HCP considerations related to patient adherence, insurance verification and patient identification reduced by M4 (absolute % reduction: 5\u201314%; 5\u20139%; and 4\u201312%, respectively). HCPs across clinic types serving Black women reported successful implementation strategies, including addressing medical mistrust and patient miseducation, staff training and reminder or tracking systems. Useful implementation strategies unique to clinic types included using electronic medical records to document whether patients were offered CAB LA (PC), designating specific days for administering injections (WH) and creating time for discussion with patients (ID).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A range of strategies across clinics that routinely serve Black cis\u2010and\u2010trans women were used to support CAB LA implementation. Implementing CAB LA in clinical settings can be bolstered by addressing population\u2010specific concerns, increasing staff\/patient education about CAB LA and modifying clinical flows. Lessons learned in EBONI can help support future integration for Black cis\u2010 and transgender women and provide valuable insights for various clinical environments.<\/jats:p><\/jats:sec><jats:sec><jats:title>ClinicalTrials.gov number<\/jats:title><jats:p>NCT05514509<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.26497","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:24:57Z","timestamp":1751441097000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Strategies for implementing long\u2010acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study"],"prefix":"10.1002","volume":"28","author":[{"given":"Katherine L.","family":"Nelson","sequence":"first","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammeka","family":"Evans Cooper","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Lawson","sequence":"additional","affiliation":[{"name":"MadeWell OBGYN  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Baker","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Mocherla","sequence":"additional","affiliation":[{"name":"Legacy Community Health Services  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Dieterich","sequence":"additional","affiliation":[{"name":"Whitman\u2010Walker Institute  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Hodge","sequence":"additional","affiliation":[{"name":"Washington Health Institute  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alftan","family":"Dyson","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Sutherland\u2010Philips","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Swygard","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Petty","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jeffery","sequence":"additional","affiliation":[{"name":"GSK  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Sutton","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-2698","authenticated-orcid":false,"given":"Courtney Peasant","family":"Bonner","sequence":"additional","affiliation":[{"name":"RTI International  Research Triangle Park North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-0976","authenticated-orcid":false,"given":"Sara M.","family":"Andrews","sequence":"additional","affiliation":[{"name":"RTI International  Research Triangle Park North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Chang","sequence":"additional","affiliation":[{"name":"RTI International  Research Triangle Park North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Budnik","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Smith","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"de Ruiter","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Czarnogorski","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-7877","authenticated-orcid":false,"given":"Nanlesta","family":"Pilgrim","sequence":"additional","affiliation":[{"name":"ViiV Healthcare  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Centers for Disease Control and Prevention.Diagnoses of HIV infection in the United States and dependent areas 2019.2021. Available from:https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc\u2010hiv\u2010surveillance\u2010report\u20102018\u2010updated\u2010vol\u201032.pdf. Accessed 14 Nov 2024."},{"key":"e_1_2_11_3_1","unstructured":"Centers for Disease Control and Prevention.Diagnoses deaths and prevalence of HIV in the United States and 6 territories and freely associated states 2022.2024. Available from:https:\/\/stacks.cdc.gov\/view\/cdc\/156509. Accessed 14 Nov 2024."},{"key":"e_1_2_11_4_1","article-title":"Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population\u2010based analysis","volume":"33","author":"Sullivan PS","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"e_1_2_11_5_1","unstructured":"Centers for Disease Control and Prevention.Information from CDC's division of HIV prevention.2023. Available from:https:\/\/www.cdc.gov\/hiv\/policies\/dear\u2010colleague\/dcl\/20231017.html. Accessed 14 Nov 2024."},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-023-01729-9"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02843-z"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002112"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.13234"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2016.1154085"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0408-3"},{"key":"e_1_2_11_12_1","unstructured":"ViiV Healthcare.Apretude PI 2021[cited April 2024]. Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215499s000lbl.pdf. Accessed 14 Nov 2024."},{"key":"e_1_2_11_13_1","unstructured":"TurnerC WagnerGPA WillcottA LonerganT HillL BlumenthaJ.Implementing long\u2010acting cabotegravir for HIV preexposure prophylaxis in a large urban HIV clinic.Poster presented at Conference on Retroviruses and Opportunistic Infections (CROI).Denver CO;March 3\u20136 2024. Poster 1108."},{"key":"e_1_2_11_14_1","unstructured":"PatelR GoldenM KeitaR DaviesM ContrerasK MayerK et\u00a0al.Feasibility of long\u2010acting injectable cabotegravir PrEP initiation and administration by community health workers and early aspects of the PrEP injection care continuum in a primary care center in Washington D.C.Poster presented at International AIDS Society (IAS).Brisbane Australia;23\u201326 July 2023. Poster LBPEE01."},{"key":"e_1_2_11_15_1","unstructured":"MillsA BrunetL MounzerK WohlfeilerMB FrostKR HsuRK et\u00a0al.Pre\u2010exposure prophylaxis with cabotegravir long\u2010acting injectable in the OPERA Cohort.Poster presentation at Conference on Retroviruses and Opportunistic Infections (CROI).Denver CO;March 3\u20136 2024. Poster 1109."},{"key":"e_1_2_11_16_1","unstructured":"MayerK BrownC FrickA RadtchenkoJ SridharG RagoneL et\u00a0al.Real\u2010world use of cabotegravir long\u2010acting for pre\u2010exposure prophylaxis: Trio Health Cohort.Poster presented at Conference on Retroviruses and Opportunistic Infections (CROI).Denver CO;March 3\u20136 2024. Poster 1110."},{"key":"e_1_2_11_17_1","unstructured":"KamyaMR BalzerLB AyiekoJ KabamiJ KakandeE ChamieG et\u00a0al.Randomized trial of SEARCH dynamic choice HIV prevention including injectable cabotegravir (CAB\u2010LA).Oral presentation at Conference on Retroviruses and Opportunistic Infections (CROI).Denver CO;March 3\u20136 2024. Poster 172."},{"key":"e_1_2_11_18_1","unstructured":"Bisom\u2010RappE CampC OskarssonJ ShielsM SpinelliMA Mayorga\u2010MunozF et\u00a0al.Rapid long\u2010acting injectable PrEP implementation in a vulnerable urban safety net clinic population.Poster presented at Conference on Retroviruses and Opportunistic Infections (CROI).Denver CO;March 3\u20136 2024. Poster 01242."},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00538-4"},{"key":"e_1_2_11_21_1","unstructured":"Delany\u2010MoretlweS VoldalE SaidiF.Initial evaluation of CAB\u2010LA safety during pregnancy in the HPTN 084 open\u2010label extension.Presented at the 25th International AIDS Conference July 2024.2024."},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","unstructured":"HolderH PilgrimN OrtizR ValentiW LiB GaudionA et\u00a0al.Patient experiences at month 6 after initiation of cabotegravir long\u2010acting (CAB LA) for PrEP in the first male gender concordant implementation science trial (PILLAR) in the United States.Poster presented at the IDWeek 2024 Conference.Los Angeles CA;2024. 16\u201319 October. Poster P1424.","DOI":"10.1093\/ofid\/ofae631.1599"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/15248399211053584"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003370"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.1343"},{"key":"e_1_2_11_26_1","unstructured":"DysonA EvansT HodgeT BarnettS SchneiderJ HullK et\u00a0al.Addressing inequities in awareness and uptake of HIV biomedical prevention for US Black women: the role of providers and Black women in designing the EBONI study.Poster presented at the 16th Annual Conference on the Science of Dissemination and Implementation in Health.Arlington VA;10\u201313 December 2023. Poster C\u2010144."},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-116"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-50"},{"key":"e_1_2_11_31_1","volume-title":"Applied qualitative research design: a total quality framework approach","author":"Roller MR","year":"2015"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/1609406919899220"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2019.0189"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002403"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-03023-9"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0142"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06214-9"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240745"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26282"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac716"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2020.0126"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000733"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26103"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26003"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26243"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.26497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:56:34Z","timestamp":1752144994000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.26497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/jia2.26497"],"URL":"https:\/\/doi.org\/10.1002\/jia2.26497","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e26497"}}